CA Stock MarketDetailed Quotes

LOBE Lobe Sciences Ltd

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayPost Market Feb 18 13:22 ET
3.66MMarket Cap-0.67P/E (TTM)

About Lobe Sciences Ltd Company

Lobe Sciences Ltd  is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Company Profile

SymbolLOBE
Company NameLobe Sciences Ltd
Founded2010
MarketCNQ
Fiscal Year Ends08-31
Address1771 Robson Street No. 1614
CityVancouver
CountryCAN
Zip CodeV6G 3B7
Phone+1 949 505-5623

Company Executives

  • Name
  • Position
  • Salary
  • Frederick D. Sancilio
  • Chairman of the Board and Chief Executive Officer
  • --
  • Mathew Lee
  • Chief Financial Officer
  • --
  • Maghsoud Dariani
  • Chief Science Officer
  • --
  • Rick Goulburn
  • Director
  • --
  • Harry Jacobson
  • Director
  • --
  • Dr. Herman Williams
  • Director
  • --
  • Wesley Ramjeet
  • Director
  • --
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.